Comprimé pelliculé. Comprimés jaunes ovaloïdes de 120 mg avec «STARLIX» marqué d’un côté et «120» de l’autre. At the end of treatment, STARLIX 60 mg and 120 mg three times daily resulted in a statistically significantly greater reductions in HbA1C compared to placebo when added to metformin (-0.4% and -0.6% for STARLIX 60 mg and STARLIX 120 mg plus metformin, respectively). The recommended dose of nateglinide alone or in combination with metformin or thiazolidinediones is 120 mg three times daily with meals. The 60 mg dose is used for patients who are close to their goal HbA1c when treatment is started. Nateglinide should be taken 30 minutes or less before a meal but should not be taken if a meal is skipped. La dose usuelle de natéglinide est 120 mg pris immédiatement ou jusqu'à 30 minutes avant chaque repas. Le dosage peut s'ajuster en fonction de votre réponse au médicament et de votre taux de sucre sanguin. 120 mg yellow, ovaloid tablets with “STARLIX” marked on one side and “120” on the other. STARLIX 180 mg film-coated tablets 180 mg red, ovaloid tablets with “STARLIX” marked on one side and “180” on the other. Starlix (nateglinide) is an oral diabetes medicine that helps control blood sugar levels. This medicine helps your body respond better to insulin produced by your pancreas. Nateglinide (INN, trade name Starlix) is a drug for the treatment of type 2 diabetes. Nateglinide was developed by Ajinomoto , a Japanese company and sold by the Swiss pharmaceutical company Novartis. The recommended dose of STARLIX is 120 mg orally three times daily before meals. The recommended dose of STARLIX is 60 mg orally three times daily before meals in patients who are near glycemic goal when treatment is initiated. Find patient medical information for Nateglinide Oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Pill with imprint STARLIX 120 is Yellow, Elliptical / Oval and has been identified as Starlix 120 mg. It is supplied by Novartis Pharmaceuticals.